GLP-1 Weight Loss Injection: Comparison of Ozempic, Mounjaro and Wegovy
GLP-1 receptor agonists are a class of medications originally developed for the treatment of type 2 diabetes. Since 2023, compounds such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) have become the focus of growing public interest — not least due to their significant effect on body weight. They mimic the endogenous hormone GLP-1 (glucagon-like peptide-1), […]

